VENTYX INVESTIGATION STATEMENT: Ventyx (Nasdaq: VTYX)

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) — If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX), please visit https://www.bfalaw.com/cases/ventyx-biosciences-inc-investigation or contact us below.

Why is Ventyx being investigated by the BFA?

Directors and officers of a company have fiduciary duties to the company and its shareholders. Bleichmar Fonti & Auld LLP is investigating whether Ventyx’s directors breached those fiduciary duties and/or committed other violations of securities laws.

Shareholders are encouraged to submit their information to learn about their rights.

Submit your information here: https://www.bfalaw.com/cases/ventyx-biosciences-inc-investigation.

What can you do?

If you are a shareholder of Ventyx Biosciences, Inc., you may have legal options. All representations are made on a contingency basis. There are no costs for youShareholders will not be responsible for any court or litigation costs. The Company will seek court approval for any fees and costs.

To speak with an attorney and get more information, visit:

https://www.bfalaw.com/cases/ventyx-biosciences-inc-investigation

Or contact us:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in class actions and shareholder litigation. It was named a Top 5 Plaintiffs Firm for 2023 by ISS SCAS and its lawyers have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Recent notable successes include BFA recovering over $900 million in value from the board of Tesla, Inc. (subject to court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/ventyx-biosciences-inc-investigation

Attorney advertising. Past results do not guarantee future results.